Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

October 31, Top 20 Shareholders

201031_Top_Holders_Report (87)

Categories: News & Announcements 2020, Top 20 ShareholdersBy Richard Mollard November 2, 2020

Related posts

2020 Annual General Meeting Notice
October 2, 2020

September 30, Top 20 Shareholders
October 1, 2020

ONJCRI Monepantel Signalling Pathway Update
September 29, 2020

LUMC COVID-19 Clarification Statement
September 28, 2020

LUMC and PAA Agreement for COVID-19 Work
September 24, 2020

200921_PharmAust Awarded FightMND Grant for Phase I Trial
September 21, 2020

Recent Articles

October 31, Top 20 Shareholders
November 2, 2020
2020 Annual General Meeting Notice
October 2, 2020
September 30, Top 20 Shareholders
October 1, 2020
ONJCRI Monepantel Signalling Pathway Update
September 29, 2020

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust @PharmAust·

👇👇👇

Epichem@epichem

In case you missed it, our CEO @ColinLaGalia presented a #webinar on "Not all heroes wear capes: Epichem #learnings in the #COVID19 Era" sharing #leadership lessons from managing and maintaining full operations through the pandemic.
Click here to watch: https://bit.ly/34x5v1N

Reply on Twitter 1328872075046522882 Retweet on Twitter 1328872075046522882 Like on Twitter 13288720750465228828 Twitter 1328872075046522882

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions